Before starting treatment, healthcare providers should obtain baseline blood pressure measurements in both sitting and standing positions to identify pre-existing orthostatic hypotension
7.4 A Phase II Study Testing Lixisenatide (Lyxumia , Adlyxin ) in PD Another phase II trial tested the GLP-1 receptor agonist lixisenatide [190] in participants with PD (NCT03439943)
NICE guidelines (NG136, NG28) recommend individualised blood pressure targets, typically below 140/90 mmHg for most people with diabetes, or below 130/80 mmHg if you have kidney, eye, or cerebrovascular disease
Im also not a big fan of hot drinks, so Ill skip coffee or tea entirely for water in the morning
This has prompted media and policy attention (FDAs recent crackdown on compounding pharmacies, insurer reconsideration of coverage)
This allows our providers to determine whether GLP-1 therapy is appropriate and to create a personalized treatment plan